Add BrightSurf on Google Email

Study identifies antidepressants that get patients well and keep them well

A major comparative study found three antidepressants - escitalopram, agomelatine, and duloxetine - to be the most effective in helping patients get well and stay well in the long term. The study, which analyzed data from over 30,000 participants, suggests that these medications can provide sustained benefits over long-term use.

SourceRadboud University Medical Center·JournalThe Lancet Psychiatry·TypeMeta-analysis·DateNov 10, 2026

Could Ozempic and Wegovy affect unborn babies?

A new study by Adelaide University found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduced blood flow to the uterus and oxygen levels in developing fetuses. The study, using pregnant sheep, raises concerns about the safety of weight-loss drugs during pregnancy.

SourceAdelaide University·JournalHeart Lung and Circulation·TypeExperimental study·DateNov 9, 2026

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

Phase 3 clinical trials involving over 1,000 participants found that those taking retatrutide, a new experimental weight-loss injectable drug, lost about a quarter of their body weight on average and experienced significant pain relief. The drug also showed benefits in reducing blood pressure, lipid levels, and systemic inflammation.

SourceNorthwestern University·JournalNew England Journal of Medicine·DateNov 8, 2026

AGS releases new framework for safe and patient-centered prescribing of obesity medications in older adults

The American Geriatrics Society (AGS) has released a new framework to assist clinicians in safely prescribing obesity medications in older adults. The framework considers age-related factors such as sarcopenia and frailty, risk of lean muscle loss, malnutrition, and dehydration.

SourceAmerican Geriatrics Society·JournalJournal of the American Geriatrics Society·TypeCase study·DateOct 29, 2026

Black children at risk for severe form of asthma, new research shows

A new UVA study finds that Black children are more likely to develop severe asthma due to harmful inflammation, regardless of environmental factors. The research suggests tailored treatments for Black children with severe symptoms, and testing for high levels of T2 inflammation in all children with difficult-to-treat asthma.

SourceUniversity of Virginia Health System·JournalJournal of Allergy and Clinical Immunology: In Practice·DateOct 16, 2026

Pharmaceutical company marketing negatively influences prescribing

A new Cochrane review finds that pharmaceutical company marketing, including payments, gifts, and free meals, leads to less appropriate prescribing habits and higher medicine costs. The review analyzed millions of prescribers and found a clear dose-response relationship between paid-for meals and inappropriate prescriptions.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateOct 8, 2026

Digital alerts support timely treatment decisions of critically ill cardiac patients

Researchers found that well-designed digital alerts can assist clinicians in high-pressure situations, prompting them to make recommended treatment decisions and recognize when patients are deteriorating. The studies demonstrated the effectiveness of electronic health record alerts in the emergency department and cardiac intensive care...

SourceMichigan Medicine - University of Michigan·JournalJACC Case Reports·TypeObservational study·DateOct 6, 2026

US pharmacy closures are hitting racial minority communities the hardest

A new study reveals that pharmacy closures are occurring disproportionately among communities with a majority of racial and ethnic minority residents. Predominantly White communities have more pharmacies per 10,000 people than neighborhoods with predominantly minority populations, leading to unequal access to healthcare services.

SourceBoston University·JournalJAMA Network Open·TypeData/statistical analysis·DateOct 2, 2026

How much do Americans spend on GLP-1 medications? VCU medical students measure drug affordability

A study by VCU medical students found that nearly 1 in 5 GLP-1 users spent at least 10% of their household income on the medications, while 7% of patients spent an average of 7% of their household income annually. The researchers emphasize the need for solutions to make GLP-1 medications more affordable, particularly among uninsured an...

SourceVirginia Commonwealth University·JournalJournal of General Internal Medicine·DateSep 28, 2026

Nasal spray brings pain relief for children treated in the emergency department

A nasal spray treatment has shown to provide rapid and effective pain relief for children in emergency departments, with 86.2% of children experiencing reduced pain 30 minutes after treatment. The treatment was well-tolerated with mild side effects, offering a simple and effective option for treating children in the emergency department.

Older Americans are taking more medications, with 1 in 5 at risk for a major drug interaction

A recent USC-led study reveals that over 1 in 5 older adults are at risk for major drug interactions, despite a decline in their prevalence. Polypharmacy and dietary supplement polypharmacy have increased, with antidepressants, statins, and antiplatelet therapies being the most commonly used medications involved in these regimens.

SourceUniversity of Southern California·JournalJAMA·TypeObservational study·DateSep 24, 2026

Microplastics may help antibiotic resistance travel farther through livestock waste

A new review suggests that microplastics can act as mobile carriers for antibiotics and antibiotic resistance genes, creating hotspots where resistance can persist and spread. The review calls for integrated treatment methods to control microplastics, antibiotics, and resistance genes.

SourceShenyang Agricultural University Collaborative Journals·JournalAgricultural Ecology and Environment·TypeLiterature review·DateSep 17, 2026

Efficacy and safety of semaglutide according to frailty status

A recent study found semaglutide to be effective in improving various clinical outcomes in patients with frailty, with greater benefits observed in those with higher frailty indices. The medication demonstrated a positive impact on health-related quality of life, highlighting its potential as a treatment option for this population.

SourceJAMA Network·JournalJAMA Cardiology·DateSep 16, 2026

The Lancet: New US Medicare pricing policies could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide, study suggests

A new US Medicare pricing policy could reshape global pharmaceutical markets, potentially driving up prices and delaying medicine launches worldwide. The study estimates that Medicare could save $5.2 billion under its initial phase, with savings rising to $21 billion if expanded to all Medicare beneficiaries.

SourceThe Lancet·JournalThe Lancet·TypeComputational simulation/modeling·DateSep 13, 2026

Protein clues in the blood may help children avoid diseases later in life

Researchers have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that can be reversed with a new class of weight loss drugs. The study found that levels of certain disease-associated proteins in children decline in response to therapy with semaglutide, a GLP-1 receptor agonis...

SourceVanderbilt University Medical Center·JournalNature Metabolism·DateSep 11, 2026

Loberamisal for acute ischemic stroke

A study published in JAMA found that intravenous loberamisal increased the proportion of patients with acute ischemic stroke achieving full functional outcomes at 90 days. The treatment resulted in a higher proportion of patients regaining full functional abilities compared to placebo.

SourceJAMA Network·JournalJAMA·DateSep 10, 2026

Weight loss injections and pregnancy – new guidelines support safe decision making

Weight loss injections can impact reproductive health, and a new study provides evidence-based guidelines for families and health professionals. The guidelines recommend that incretin-based medication therapy should not be deliberately continued throughout pregnancy, but women who used the injections without realizing they were pregnan...

SourceUniversity of Plymouth·JournalObesity Reviews·TypeSystematic review·DateSep 9, 2026

Paracetamol use during pregnancy is linked to changed reproductive development in daughters

Researchers found that girls whose mothers took paracetamol during pregnancy had smaller ovaries, fewer ovarian follicles, and lower levels of reproductive hormones at three months old. The study, published in Human Reproduction Open, suggests that foetal exposure to paracetamol may affect reproductive development, but the findings do ...

SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction Open·TypeObservational study·DateSep 8, 2026

River drinking water sources may face greater antibiotic resistance risks than reservoirs, study finds

A study of 13 drinking water sources in China's Poyang Lake region reveals that river-type sources carry higher risks from antibiotics and resistant bacteria than reservoir-type sources. The findings highlight the importance of considering water source type when designing monitoring and pollution-control strategies.

SourceShenyang Agricultural University Collaborative Journals·JournalBiocontaminant·TypeExperimental study·DateSep 8, 2026